A Study of LY3502970 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

133

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

November 2, 2020

Study Completion Date

November 2, 2020

Conditions

Healthy

Interventions

DRUG

LY3502970

Administered orally.

DRUG

Placebo

Administered orally.

DRUG

Atorvastatin

Administered orally.

DRUG

Simvastatin

Administered orally.

DRUG

Midazolam

Administered orally.

Trial Locations (1)

Covance Dallas, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03929744 - A Study of LY3502970 in Healthy Participants | Biotech Hunter | Biotech Hunter